Product Overview
Trans-Tranilast | T2270 | TargetMol Chemicals
CAS: 70806-55-2
Smiles: COc1c(cc(cc1)/C=C/C(=O)Nc1c(cccc1)C(=O)O)OC
Formula: C18H17NO5
Pathway: Endocrinology/Hormones
Target: RAAS
Receptor: N/A
Bioactivity: Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Molecular Weight: 327, 33
